Managing Rivaroxaban
For the app is intended for general practitioners, cardiologists, haematologists, neurologists, anaesthetists, emergency specialists, and surgeons.
Overview · Full Intel report in progress
Managing Rivaroxaban is an established medical app that is completely free.
What is Managing Rivaroxaban?
Current Momentum
v1.5 · 69mo ago
ZombieLast updated 2088d ago. 5 versions tracked.
Competition
Rivals identification in progress
7-Day Rank Pulse 🇺🇸
MedicalNo ranking data
Rating Pulse 🇺🇸
Gathering signals...
What makes this app unique?
What Does It Look Like?
What Are The Key Features?
Provides dosing guidance based on specific clinical indications and published data sheets.
Offers quick access to pharmacology, potential drug interactions, and common side-effects.
Provides clinical advice for managing patients in the event of bleeding complications.
Recommends specific timelines for stopping treatment prior to surgical procedures.
Assists clinicians in interpreting patient coagulation test results.
How much does it cost?
Who Built It?
HealthObs
Providing clinical decision support tools for healthcare professionals managing anticoagulant therapies. Focused on evidence-based dosing and emergency management protocols.
Portfolio
3
Apps
What other apps does HealthObs make?
Explore the full HealthObs report
Portfolio breakdown, audience, momentum, and every app published by HealthObs.
Analysis in progress, available soon
What do users think recently?
Analysis in progress, available soon
Analysis in progress, available soon
What is the competitive landscape for Managing Rivaroxaban?
How's The Medical Market?
How does it evolve in the Medical market?
Rank progression
1 active ranking tracked — 30-day window
Strategic analysis coming soon
SWOT, key takeaways & outlook
The outtake for Managing Rivaroxaban
Key Takeaways
This app serves as a clinical decision support tool designed to standardize the management of patients on rivaroxaban across various medical specialties.
Where Is It Heading?
Trend analysis
Available very soon